1. Home
  2. CRSP vs BB Comparison

CRSP vs BB Comparison

Compare CRSP & BB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRSP
  • BB
  • Stock Information
  • Founded
  • CRSP 2013
  • BB 1984
  • Country
  • CRSP Switzerland
  • BB Canada
  • Employees
  • CRSP N/A
  • BB N/A
  • Industry
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • BB
  • Sector
  • CRSP Health Care
  • BB
  • Exchange
  • CRSP Nasdaq
  • BB Nasdaq
  • Market Cap
  • CRSP 3.4B
  • BB 3.0B
  • IPO Year
  • CRSP 2016
  • BB 1997
  • Fundamental
  • Price
  • CRSP $47.87
  • BB $5.24
  • Analyst Decision
  • CRSP Buy
  • BB Buy
  • Analyst Count
  • CRSP 21
  • BB 6
  • Target Price
  • CRSP $75.42
  • BB $3.85
  • AVG Volume (30 Days)
  • CRSP 2.7M
  • BB 27.3M
  • Earning Date
  • CRSP 02-11-2025
  • BB 04-02-2025
  • Dividend Yield
  • CRSP N/A
  • BB N/A
  • EPS Growth
  • CRSP N/A
  • BB N/A
  • EPS
  • CRSP N/A
  • BB N/A
  • Revenue
  • CRSP $37,314,000.00
  • BB $638,000,000.00
  • Revenue This Year
  • CRSP $227.76
  • BB N/A
  • Revenue Next Year
  • CRSP $353.05
  • BB N/A
  • P/E Ratio
  • CRSP N/A
  • BB N/A
  • Revenue Growth
  • CRSP N/A
  • BB N/A
  • 52 Week Low
  • CRSP $36.52
  • BB $2.01
  • 52 Week High
  • CRSP $90.62
  • BB $6.24
  • Technical
  • Relative Strength Index (RSI)
  • CRSP 58.27
  • BB 55.70
  • Support Level
  • CRSP $38.28
  • BB $5.63
  • Resistance Level
  • CRSP $55.88
  • BB $6.24
  • Average True Range (ATR)
  • CRSP 2.87
  • BB 0.38
  • MACD
  • CRSP 1.07
  • BB -0.01
  • Stochastic Oscillator
  • CRSP 54.50
  • BB 52.89

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About BB BlackBerry Limited

BlackBerry, once known for being the world's largest smartphone manufacturer, is now exclusively a software provider with a stated goal of end-to-end secure communication for enterprises. The firm provides endpoint management and protection to enterprises, specializing in regulated industries like government, as well as embedded software to the automotive, medical, and industrial markets.

Share on Social Networks: